Clinical Trial Update: Study of the Drug B11-FC (Botulism Treatment) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes that B11-FC is being studied as a botulism treatment in Phase 1/Phase 2 and has not yet recruited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Botulism

Drugs mentioned

• B11-FC

Snippet

Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Conditions: Botulism | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING